These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17049769)

  • 41. Pore size distribution in tablets measured with a morphological sieve.
    Wu YS; van Vliet LJ; Frijlink HW; van der Voort Maarschalk K
    Int J Pharm; 2007 Sep; 342(1-2):176-83. PubMed ID: 17580106
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Process control and scale-up of pharmaceutical wet granulation processes: a review.
    Faure A; York P; Rowe RC
    Eur J Pharm Biopharm; 2001 Nov; 52(3):269-77. PubMed ID: 11677069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New insights into segregation during tabletting.
    Lakio S; Siiriä S; Räikkönen H; Airaksinen S; Närvänen T; Antikainen O; Yliruusi J
    Int J Pharm; 2010 Sep; 397(1-2):19-26. PubMed ID: 20600718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of process parameters and equipment on dry foam formulation properties using indomethacin as model drug.
    Sprunk A; Page S; Kleinebudde P
    Int J Pharm; 2013 Oct; 455(1-2):189-96. PubMed ID: 23891743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advantages of celecoxib nanosuspension formulation and transformation into tablets.
    Dolenc A; Kristl J; Baumgartner S; Planinsek O
    Int J Pharm; 2009 Jul; 376(1-2):204-12. PubMed ID: 19426794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Construction, operation and initial experience with a laboratory apparatus for fluid-bed coating of particles].
    Kala H; Hennig D; Moldenhauer H; Zessin G
    Pharmazie; 1983 Dec; 38(12):879-81. PubMed ID: 6669619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Process design applied to optimise a directly compressible powder produced via a continuous manufacturing process.
    Gonnissen Y; Gonçalves SI; De Geest BG; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2008 Mar; 68(3):760-70. PubMed ID: 17964129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In-line monitoring of particle size in a fluid bed granulator: investigations concerning positioning and configuration of the sensor.
    Roßteuscher-Carl K; Fricke S; Hacker MC; Schulz-Siegmund M
    Int J Pharm; 2014 May; 466(1-2):31-7. PubMed ID: 24589125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of an oral rutin nanocrystal formulation.
    Mauludin R; Müller RH; Keck CM
    Int J Pharm; 2009 Mar; 370(1-2):202-9. PubMed ID: 19114097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of the spraying conditions and nozzle design on the shape and size distribution of particles obtained with supercritical fluid drying.
    Bouchard A; Jovanović N; de Boer AH; Martín A; Jiskoot W; Crommelin DJ; Hofland GW; Witkamp GJ
    Eur J Pharm Biopharm; 2008 Sep; 70(1):389-401. PubMed ID: 18534833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of size and density of particles on flow properties of granules.
    Czarnecki W; Szumiło M; Wasik D
    Acta Pol Pharm; 2009; 66(5):553-61. PubMed ID: 19894652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single-step granulation/tabletting of different grades of lactose: a comparison with high shear granulation and compression.
    Keleb EI; Vermeire A; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2004 Jul; 58(1):77-82. PubMed ID: 15207540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Application of multivariate methods to compression behavior evaluation of directly compressible materials.
    Haware RV; Tho I; Bauer-Brandl A
    Eur J Pharm Biopharm; 2009 May; 72(1):148-55. PubMed ID: 19084596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation of pellets of different shape and their characterization.
    Chopra R; Newton JM; Alderborn G; Podczeck F
    Pharm Dev Technol; 2001 Nov; 6(4):495-503. PubMed ID: 11775951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying.
    Sansone F; Aquino RP; Del Gaudio P; Colombo P; Russo P
    Eur J Pharm Biopharm; 2009 May; 72(1):206-13. PubMed ID: 18996478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An innovative method for the preparation of high API-loaded hollow spherical granules for use in controlled-release formulation.
    Asada T; Kobiki M; Ochiai Y; Iwao Y; Itai S
    Int J Pharm; 2017 May; 523(1):167-175. PubMed ID: 28323098
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
    Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
    Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Visualisation of natural aquatic colloids and particles -- a comparison of conventional high vacuum and environmental scanning electron microscopy.
    Doucet FJ; Lead JR; Maguire L; Achterberg EP; Millward GE
    J Environ Monit; 2005 Feb; 7(2):115-21. PubMed ID: 15690091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Particle engineering techniques for inhaled biopharmaceuticals.
    Shoyele SA; Cawthorne S
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1009-29. PubMed ID: 17005293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.